Cargando…
Response to antiseizure medications in epileptic patients with malformation of cortical development
BACKGROUND: Malformation of cortical development (MCD) is one of the most common causes of pharmacoresistant epilepsy. Improving the knowledge of antiseizure medications (ASMs) treatment response in epileptic patients with MCD is crucial for optimal treatment options, either pharmacological therapy...
Autores principales: | Chen, Wei, Jin, Bo, Aung, Thandar, He, Chenmin, Chen, Cong, Wang, Shan, Ding, Yao, Ding, Fang, Wang, Chao, Li, Hong, Jiang, Biao, Zheng, Zhe, Dai, Haibin, Zhu, Junming, Geng, Yu, Ding, Meiping, Wang, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8521419/ https://www.ncbi.nlm.nih.gov/pubmed/34671424 http://dx.doi.org/10.1177/17562864211050027 |
Ejemplares similares
-
Hippocampal Malrotation Could Be Less Significant in Epilepsy Caused by Focal Cortical Dysplasia Type I and Type II
por: He, Chenmin, et al.
Publicado: (2022) -
Patterns of hypometabolism in frontal lobe epilepsy originating in different frontal regions
por: Zhao, Zexian, et al.
Publicado: (2022) -
Clinical characteristics of low‐grade tumor‐related epilepsy and its predictors for surgical outcome
por: He, Chenmin, et al.
Publicado: (2021) -
Small Lesion Size Is Associated with Sleep-Related Epilepsy in Focal Cortical Dysplasia Type II
por: Jin, Bo, et al.
Publicado: (2018) -
Clinical Characteristics and Prognostic Significance of Subclinical Seizures in Focal Epilepsy: A Retrospective Study
por: He, Chenmin, et al.
Publicado: (2022)